Skip to content
value.today

Knopp Biosciences LLC

Total raised
$69 M
5 rounds on record
Latest round
$13 M
Jun 2020
First round on record
Jul 2012
Today
Private
No later event on record

Funding rounds

5 counted as startup funding, 1 other private sales on record. Open the number of investors for the round's details.

Funding rounds of Knopp Biosciences LLC
MonthRaisedRaiseSizeInvestorsSoldFiling
Jun 2020$13 MNo. 5$10 to $50 million

Knopp Biosciences LLC: Raise no. 5, Jun 2020

Investors in this round

24 investors had bought by the notice of Oct 27, 2020: 24 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $26 M offered; $13 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
$472,888
Finders' fees
none
Paid to its own people
$2,600,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and payments to its own people as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Calman A. Prussin · Executive Officer
  • Gregory T. Hebrank · Executive Officer, Director, Promoter · LLC Manager
  • James A. Mather · Executive Officer
  • Mark A. Kreston · Executive Officer
  • Michael E. Bozik · Executive Officer, Director, Promoter · LLC Manager
  • Steven A. Dworetzky · Executive Officer
  • Thomas V. Petzinger, Jr. · Executive Officer, Director, Promoter · LLC Manager
  • Benjamin A. Gomez · Director · LLC Manager
  • C. David Adair · Director · LLC Manager
  • Jeffrey S. McCormick · Director · LLC Manager
  • Stephen E Butts · Director · LLC Manager

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Saturn Capital, Inc. (CRD 15412) · Boston, MassachusettsSold in all US states

Remarks in the notice

  • On the amounts: “The offering amount takes into account the exercise of warrants”

Signed by Gregory T. Hebrank, EVP, Corporate Operations & Finance. Source: SEC Form D and 1 amendment, newest notice filed Oct 27, 2020. Read the notice at the SEC.

equity, optionsSEC
Mar 2020$1 MNo. 4Under $2 million

Knopp Biosciences LLC: Raise no. 4, Mar 2020

Investors in this round

1 investor had bought by the notice of Mar 5, 2020: 1 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$1 M of $3 M offered; $2 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$520,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Calman A. Prussin · Executive Officer
  • Gregory T. Hebrank · Executive Officer, Director, Promoter · LLC Manager
  • James A. Mather · Executive Officer
  • Mark A. Kreston · Executive Officer
  • Michael E. Bozik · Executive Officer, Director, Promoter · LLC Manager
  • Steve A. Dworetzky · Executive Officer
  • Benjamin A. Gomez · Director · LLC Manager
  • Jeffrey S. McCormick · Director · LLC Manager
  • Thomas V. Petzinger, Jr. · Director, Promoter · LLC Manager

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “None.”

Signed by Gregory T. Hebrank, EVP, Corporate Operations & Finance. Source: SEC Form D, newest notice filed Mar 5, 2020. Read the notice at the SEC.

debt, optionsSEC
Feb 2019$13 MNo. 3$10 to $50 million

Knopp Biosciences LLC: Raise no. 3, Feb 2019

Investors in this round

26 investors had bought by the notice of Mar 2, 2020: 26 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$13 M of $26 M offered; $13 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
$263,750
Finders' fees
none
Paid to its own people
$4,000,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and payments to its own people as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Calman A. Prussin · Executive Officer
  • Gregory T. Hebrank · Executive Officer, Director, Promoter · LLC Manager
  • James A. Mather · Executive Officer
  • Mark A. Kreston · Executive Officer
  • Michael E. Bozik · Executive Officer, Director, Promoter · LLC Manager
  • Steven A. Dworetzky · Executive Officer
  • Benjamin A. Gomez · Director · LLC Manager
  • Jeffrey S. McCormick · Director · LLC Manager
  • Thomas V. Petzinger, Jr. · Director, Promoter · LLC Manager

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Saturn Capital, Inc. (CRD 15412) · Boston, MassachusettsSold in all US states

Remarks in the notice

  • On the amounts: “Includes value of warrants issued and estimated value of warrants to be issued to the Placement Agent”

Signed by Gregory T. Hebrank, EVP, Corporate Operations & Finance. Source: SEC Form D and 2 amendments, newest notice filed Mar 2, 2020. Read the notice at the SEC.

equity, optionsSEC
May 2014$28 MNo. 2$10 to $50 million

Knopp Biosciences LLC: Raise no. 2, May 2014

Investors in this round

61 investors had bought by the notice of Jul 24, 2018: 61 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$28 M of $31 M offered; $3 M still to sell
Smallest investment taken
no minimum stated
What was sold
debt, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
$677,749
Finders' fees
none
Paid to its own people
$5,200,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks sales commissions and payments to its own people as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Calman A. Prussin · Executive Officer
  • Gregory T. Hebrank · Executive Officer, Director, Promoter · LLC Manager
  • Michael E. Bozik · Executive Officer, Director, Promoter · LLC Manager
  • Steven A. Dworetzky · Executive Officer
  • Thomas V. Petzinger, Jr. · Executive Officer, Director, Promoter · LLC Manager
  • Benjamin A. Gomez · Director · LLC Manager
  • Jeffrey S. McCormick · Director · LLC Manager

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

  • Stillpoint Capital, LLC (CRD 133146) · Tampa, FloridaSold in CA, CT, FL, MA, MD, NJ, NV, NY, OH, PA, and outside the US
  • MIP Global, Inc. (CRD 164640) · Guaynabo, San Juan, Puerto RicoSold in CA, CT, FL, MA, MD, NC, NJ, NV, NY, OH, PA, and outside the US
  • Pickwick Capital Partners, LLC (CRD 130672) · White Plains, New YorkSold in CA, CT, DC, IL, MA, MD, ME, NJ, NY, PA, TX, VA, WA
  • Saturn Capital, Inc. (CRD 15412) · Boston, MassachusettsSold in CT, FL, IL, KY, MA, NY, OH, PA, TX, WI

Remarks in the notice

  • On the amounts: “Includes warrants issued to the placement agent”

Signed by Gregory T. Hebrank, EVP, Corporate Operations & Finance. Source: SEC Form D and 8 amendments, newest notice filed Jul 24, 2018. Read the notice at the SEC.

debt, optionsSEC
Jul 2012$15 MNo. 1$10 to $50 million

Knopp Biosciences LLC: Raise no. 1, Jul 2012

Investors in this round

78 investors had bought by the notice of Jun 19, 2020: 78 accredited, none not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$15 M of $30 M offered; $15 M still to sell
Smallest investment taken
no minimum stated
What was sold
equity, options or other rights to buy securities, securities to be acquired by exercising them
Exemption claimed
  • Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last
more than a year
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
$2,500,000 (proceeds used for payments to executives, directors or promoters)
Estimates
the notice marks payments to its own people as estimates
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Calman A. Prussin · Executive Officer
  • Gregory T. Hebrank · Executive Officer, Director, Promoter · LLC Manager
  • James A. Mather · Executive Officer
  • Mark A. Kreston · Executive Officer
  • Michael E. Bozik · Executive Officer, Director, Promoter · LLC Manager
  • Steven A. Dworetzky · Executive Officer
  • Benjamin A. Gomez · Director · LLC Manager
  • Jeffrey S. McCormick · Director · LLC Manager
  • Thomas V. Petzinger, Jr. · Director, Promoter · LLC Manager

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On the amounts: “The offering amount takes into account the exercise of warrants.”

Signed by Gregory T. Hebrank, EVP, Corporate Operations & Finance. Source: SEC Form D and 8 amendments, newest notice filed Jun 19, 2020. Read the notice at the SEC.

equity, optionsSEC
Aug 2010$140 MIssued in a merger or acquisition$50 to $250 million

Knopp Biosciences LLC: Private sale, Aug 2010

Investors in this round

90 investors had bought by the notice of Sep 3, 2010: 81 accredited, 9 not accredited.

Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.

What the notice says

Amount sold
$140 M of $140 M offered
Smallest investment taken
no minimum stated
What was sold
equity, other: Profits Interests
Exemption claimed
  • 06
Meant to last
a year or less
Issuer's revenue
Not disclosed
Sales commissions
none
Finders' fees
none
Paid to its own people
none (proceeds used for payments to executives, directors or promoters)
The company
Limited Liability Company, incorporated in Delaware

People named in the notice

  • Evan W. Ingersoll · Executive Officer
  • Gregory T. Hebrank · Director, Executive Officer, Promoter · LLC Manager
  • Michael E. Bozik · Director, Executive Officer, Promoter · LLC Manager
  • Thomas W. Petzinger, Jr. · Director, Executive Officer, Promoter · LLC Manager
  • Valentin K. Gribkoff · Executive Officer
  • Benjamin A. Gomez · Director · LLC Manager
  • Jeffrey S. McCormick · Director · LLC Manager

Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.

Paid to sell the round

No one: the notice names no broker or finder paid to sell it.

Remarks in the notice

  • On a merger: “The securities were issued in connection with a merger.”

Signed by Michael E. Bozik, President and CEO. Source: SEC Form D, newest notice filed Sep 3, 2010. Read the notice at the SEC.

equitySEC

Source: SEC Form D. Each row is one private sale of securities with the running total of its newest notice. The form does not name the series or the investors; rounds are numbered in the order they were filed. A round's details show what its notice does say: accredited and other investors, the smallest investment taken, the exemption claimed, fees, the people named and the brokers paid to sell it.

How it makes money#

What its filings and its own website say, sentence by sentence, each with its source.

  • Knopp Biosciences LLC chose not to state its revenue in its newest notice of a funding round (Oct 2020).

    SEC Form D · Oct 2020

  • The industry group it chose in its notices: Biotechnology.

    SEC Form D · Oct 2020

That is all the official record says: Knopp Biosciences LLC has not published its revenue in a filing we can read, and no other official source covers it. Revenue figures come from crowdfunding filings (SEC Form C) and from annual reports once a company is listed.

Products and services#

No products or services on record: no website is on record for it in an official source (its SEC filings, Wikidata).

Investors#

No investor of Knopp Biosciences LLC is named in an official source we use. Its funding notices give only how many investors bought, not who they are.

Source: SEC Form 3 statements, SEC Form N-PORT fund reports, Wikidata, value.today research. Names come from filings that do name holders: the preferred stock each holder had when the company registered its shares (Form 3), private shares in US mutual funds' portfolio reports (N-PORT), and Wikidata. None ties a name to one funding round, so this list is per company, and it is not complete: the 5 rounds above had up to 78 investors.

Executives and directors

As the company named them in its notices. Directors of a funded startup are often partners of its investors.

People named by Knopp Biosciences LLC
NameRoleNamed in
Calman A. PrussinExecutive officerOct 2020
Gregory T. HebrankLLC ManagerOct 2020
James A. MatherExecutive officerOct 2020
Mark A. KrestonExecutive officerOct 2020
Michael E. BozikLLC ManagerOct 2020
Steven A. DworetzkyExecutive officerOct 2020
Thomas V. Petzinger, Jr.LLC ManagerOct 2020
Steve A. DworetzkyExecutive officerMar 2020
Steven V. DworetzkyExecutive officerApr 2015
Frank J. Lucchino, Jr.Executive officerJul 2013
Steven J. DworetzkyExecutive officerJul 2013
Suresh J. KhemaniExecutive officerJul 2013
Thomas J. Petzinger, Jr.LLC ManagerJul 2013
Evan W. IngersollExecutive officerNov 2012
Steven W. DworetzkyExecutive officerNov 2012
Suresh W. KhemaniExecutive officerNov 2012
Thomas W. Petzinger, Jr.LLC ManagerNov 2012
Valentin K. GribkoffExecutive officerSep 2010
Benjamin A. GomezLLC ManagerOct 2020
C. David AdairLLC ManagerOct 2020
Gregory T. HebrankLLC ManagerOct 2020
Jeffrey S. McCormickLLC ManagerOct 2020
Michael E. BozikLLC ManagerOct 2020
Stephen E ButtsLLC ManagerOct 2020
Thomas V. Petzinger, Jr.LLC ManagerOct 2020
Shane V. KovacsLLC ManagerJun 2017
Thomas J. Petzinger, Jr.LLC ManagerJul 2013
Thomas W. Petzinger, Jr.LLC ManagerNov 2012
Gregory T. HebrankLLC ManagerOct 2020
Michael E. BozikLLC ManagerOct 2020
Thomas V. Petzinger, Jr.LLC ManagerOct 2020
Thomas J. Petzinger, Jr.LLC ManagerJul 2013
Thomas W. Petzinger, Jr.LLC ManagerNov 2012